North American Dermatology Devices Market - The dermatology devices market in the U.S. is expected t

Dermatology devices assist in enhancing and improving the patient’s skin conditions. It is used by dermatologists and surgeons for diagnosing skin disorders. With the use of dermatological devices, dermatologists are able to identify the skin disorders at an early stage. The diagnostic devices covered in this segment include dermatoscopes, microscopes, and imaging technologies, such as MRI systems, CT scanners, ultrasound equipment, and the recently approved optical coherence tomography (OCT) scanners by the Food and Drug Administration (FDA) & CE certification. The dermatology treatment devices have been segmented into electrosurgical equipment, cryotherapy devices, LED devices, lasers, and microdermabrasion devices.

The major factors driving the demand for dermatological devices in the U.S. are the desire for youthful appearance, increasing incidence rates of skin diseases, increasing trend towards non-invasive aesthetic procedures, and technological advancements. People are becoming more conscious about their appearance and are aware of the skin disorders caused due to exposure to the sun. Dermatological devices are used for the treatment of various skin indications such as scars, psoriasis, acne, skin cancer, varicose veins, pigments, and vascular lesions. Furthermore, technical advances in both diagnostic devices and treatment devices have had positive impacts on the dermatology devices market. These technologies quickly and non-invasively permit visualization deeper into the skin to detect evidence of malignant changes.

Cosmetic surgeries and dermatological treatment are progressing steadily, which has resulted in fueling the overall demand of the dermatology diagnostic devices market. The main purpose of these dermatology devices is to assist in identifying and monitoring a patient’s skin condition. With the growing awareness of skin disorders among the recent population, there is a rising incidence of dermatological procedures in the market. This has significantly laid a positive impact on the growing dependence of such innovative dermatological diagnostic techniques.

The dermatology devices market in the U.S. is expected to grow at a CAGR of 10.0% from 2016 to 2021. The imaging techniques segment accounted for the largest share of 82.7% of the dermatology diagnostic devices market in 2013. This segment is expected to grow at a CAGR of 8.0% during the forecast period of 2016 to 2021. The LED light therapy devices segment accounted for the largest share of 39.9% of the overall dermatology treatment devices market in 2014. This segment is expected to grow at a CAGR of 11.1% from 2016 to 2021.

In North America, the demand from the population for gaining glowing skin that is completely free of ache, pimples, or blemishes have given rise to a wide range of dermatological treatments. Such growing incidence of non-invasive aesthetic procedures have progressed the demand for dermatological diagnostic devices market in the U.S.

In-depth market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at based on key facts, annual financial information from SEC filings, annual reports, and interviews with industry experts and key opinion leaders, such as CEOs, directors, and marketing executives. Top market players that have established their presence in the U.S. dermatology devices market are Heine Optotechnik (Germany), Optomed Oy (Finland), FotoFinder Systems (Germany), Michelson Diagnostics (UK), Genesis Biosystems (U.S.), Ellipse A/S (Denmark), Alma Lasers (Israel), Palomar Technologies (U.S.), GE Healthcare (UK), and Philips Healthcare (Netherlands), Verisante Technology, Inc. (Canada), Welch Allyn (U.S.), Carl Zeiss Meditec, Inc. (U.S.), Hitachi (Japan), Leica Microsystems (Germany), Olympus (Japan), Toshiba Medical Systems (Japan), Siemens Medical Systems (Germany), and MELA Sciences, Inc. (U.S.), among others.